| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Institut für Organische Chemie, Auf der Morgenstelle 18 [K. M., J. B., K-P. Z.], Medizinische Klinik und Poliklinik, Otfried-Müller-Strasse 10 [J. B., G. E.], and Institut für Physiologische Chemie, Hoppe-Seyler-Strasse 4 [R. G.], Universität Tübingen, D-72076 Tübingen, Germany
Recent studies of our group have shown that the oxidation of the substituted anthraquinone skeleton is involved in the biotransformation of mitoxantrone. In this report the importance of this process with regard to the mode of action of the drug is investigated.
This communication describes a new high performance liquid chromatography separation for mitoxantrone and its metabolites allowing the direct coupling of high performance liquid chromatography to mass spectrometry. Application of this technique to bile of mitoxantrone-treated pigs reveals the formation of several metabolites in addition to the drug-derived compounds found in urine. Seven biliary metabolites are identified as thioether derivatives of mitoxantrone and its side chain oxidation products. Independent synthesis and structural elucidation of 3 thioether conjugates of the drug provides unequivocal evidence that the hydroquinone moiety of mitoxantrone is the site of reaction with glutathione. Furthermore, the formation of the thioether conjugates in HepG2 hepatoma cells and in rat hepatocytes during cell incubations is demonstrated.
Inhibition of cytochrome P-450 with metyrapone prevents the formation of the thioether conjugates and leads to a complete loss of the cytotoxicity of mitoxantrone in HepG2 cells and rat hepatocytes up to concentrations of 200 to 400 µM thereby indicating that mitoxantrone has a negligible effect by itself. Rat hepatocytes were found to be more susceptible for the oxidation-induced cytotoxicity than HepG2 cells. These results demonstrate that the acute cytotoxicity of mitoxantrone depends on prior oxidation of its 1,4-dihydroxy-5,8-diaminoanthraquinone moiety.
1 This research was supported by the Deutsche Forschungsgemeinschaft (SFB 120).
2 To whom requests for reprints should be addressed.
Received 5/13/93. Accepted 8/26/93.
This article has been cited by other articles:
![]() |
S. E. Cohen, E. Kokkotou, S. B. Biddinger, T. Kondo, R. Gebhardt, J. Kratzsch, C. S. Mantzoros, and C. R. Kahn High Circulating Leptin Receptors with Normal Leptin Sensitivity in Liver-specific Insulin Receptor Knock-out (LIRKO) Mice J. Biol. Chem., August 10, 2007; 282(32): 23672 - 23678. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Buschini, P. Poli, and C. Rossi Saccharomyces cerevisiae as an eukaryotic cell model to assess cytotoxicity and genotoxicity of three anticancer anthraquinones Mutagenesis, January 1, 2003; 18(1): 25 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. D. Renner, G. Piperopoulos, R. Gebhardt, G. Ehninger, and K.-P. Zeller The Oxidative Biotransformation of Losoxantrone (CI-941) Drug Metab. Dispos., April 1, 2002; 30(4): 464 - 478. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Diah, P. K. Smitherman, J. Aldridge, E. L. Volk, E. Schneider, A. J. Townsend, and C. S. Morrow Resistance to Mitoxantrone in Multidrug-resistant MCF7 Breast Cancer Cells: Evaluation of Mitoxantrone Transport and the Role of Multidrug Resistance Protein Family Proteins Cancer Res., July 1, 2001; 61(14): 5461 - 5467. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Lim, M. J. Parr, D. Masin, N. L. McIntosh, T. D. Madden, G. Zhang, S. Johnstone, and M. B. Bally Kupffer Cells Do Not Play a Role in Governing the Efficacy of Liposomal Mitoxantrone Used to Treat a Tumor Model Designed to Assess Drug Delivery to Liver Clin. Cancer Res., November 1, 2000; 6(11): 4449 - 4460. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Parker, S. M. Cutts, C. Cullinane, and D. R. Phillips Formaldehyde activation of mitoxantrone yields CpG and CpA specific DNA adducts Nucleic Acids Res., February 15, 2000; 28(4): 982 - 990. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Morrow, P. K. Smitherman, S. K. Diah, E. Schneider, and A. J. Townsend Coordinated Action of Glutathione S-Transferases (GSTs) and Multidrug Resistance Protein 1 (MRP1) in Antineoplastic Drug Detoxification. MECHANISM OF GST A1-1- AND MRP1-ASSOCIATED RESISTANCE TO CHLORAMBUCIL IN MCF7 BREAST CARCINOMA CELLS J. Biol. Chem., August 7, 1998; 273(32): 20114 - 20120. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |